MURPHY JOHN RAYMOND — SEC insider filings
SEC reporting owner CIK 1275195. 35 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-08-06 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 50,000 shares, $61,271 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 14 legs across 14 filings — 32,752 shares, $3,372,766 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 12,354 shares @ $37.20 ($459,569) in Apria, Inc., filed 2022-01-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| O REILLY AUTOMOTIVE INC (ORLY) | Director | 16 | — | 11 legs · 8,261 sh · $2,524,563 | 6 |
| Apria, Inc. (APR) | Director | 3 | — | 1 leg · 12,354 sh · $459,569 | 13 |
| Summit Materials, Inc. (SUM) | Director | 9 | — | 2 legs · 12,137 sh · $388,635 | 11 |
| Cadrenal Therapeutics, Inc. (CVKD) | Director | 7 | 4 legs · 50,000 sh · $61,271 | — | 5 |
Insider filings — MURPHY JOHN RAYMOND
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 2,595 @ $88.67 | EDGAR |
| 2026-05-18 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Grant/award (A): 2,035 @ $88.49 | EDGAR |
| 2025-11-06 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 3,125 @ $92.60 | EDGAR |
| 2025-05-20 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Grant/award (A): 131 @ $1,381.66 · Sale (S): 200 @ $1,379 | EDGAR |
| 2025-01-24 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Grant/award (A): 173 @ $1,012.06 | EDGAR |
| 2024-02-15 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 269 @ $1,039.28 | EDGAR |
| 2024-01-19 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-11-02 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 250 @ $929.66 | EDGAR |
| 2023-10-06 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Purchase (P): 17,331 @ $0.70 · Purchase (P): 2,669 @ $0.69 | EDGAR |
| 2023-10-02 | 4 | Summit Materials, Inc. (SUM) | Conversion (C): 4,274 · Conversion (C): 4,274 (derivative) | EDGAR |
| 2023-05-23 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Grant/award (A): 169 @ $954.30 | EDGAR |
| 2023-05-04 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 300 @ $924.56 | EDGAR |
| 2023-03-22 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Purchase (P): 10,000 @ $1.39 | EDGAR |
| 2023-03-16 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Purchase (P): 20,000 @ $1.67 | EDGAR |
| 2023-03-01 | 4 | Summit Materials, Inc. (SUM) | Option exercise (M): 3,815 · Option exercise (M): 3,815 (derivative) @ $0 | EDGAR |
| 2023-02-24 | 4 | Summit Materials, Inc. (SUM) | Grant/award (A): 4,038 (derivative) @ $0 | EDGAR |
| 2023-02-22 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 300 @ $850.06 | EDGAR |
| 2023-01-24 | 4 | Cadrenal Therapeutics, Inc. (CVKD) | Conversion (C): 514,792 · Conversion (C): 514,792 (derivative) | EDGAR |
| 2022-08-04 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 300 @ $705.49 | EDGAR |
| 2022-05-17 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Grant/award (A): 248 @ $635.62 | EDGAR |
| 2022-03-29 | 4 | Apria, Inc. (APR) | Disposition to issuer (D): 13,799 (derivative) @ $32.17 · Disposition to issuer (D): 17,249 (derivative) @ $32.17 · Disposition to issuer (D): 5,059 (derivative) @ $37.50 | EDGAR |
| 2022-03-03 | 4 | Summit Materials, Inc. (SUM) | Grant/award (A): 3,815 (derivative) @ $0 | EDGAR |
| 2022-03-01 | 4 | Summit Materials, Inc. (SUM) | Option exercise (M): 4,374 · Option exercise (M): 4,374 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Apria, Inc. (APR) | Option exercise (M): 3,450 @ $5.33 · Tax withholding (F): 494 @ $37.24 · Option exercise (M): 5,750 @ $8.28 · Tax withholding (F): 1,279 @ $37.24 · Option exercise (M): 5,750 @ $5.33 · Tax withholding (F): 823 @ $37.24 · +4 more | EDGAR |
| 2021-11-09 | 4 | Summit Materials, Inc. (SUM) | Sale (S): 5,137 @ $37.99 | EDGAR |
| 2021-06-14 | 4 | Apria, Inc. (APR) | Grant/award (A): 5,059 (derivative) @ $0 | EDGAR |
| 2021-05-18 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Grant/award (A): 272 @ $553.33 | EDGAR |
| 2021-05-12 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 472 @ $561.84 | EDGAR |
| 2021-04-01 | 4 | Summit Materials, Inc. (SUM) | Grant/award (A): 4,374 (derivative) @ $0 | EDGAR |
| 2021-03-22 | 4 | Summit Materials, Inc. (SUM) | Sale (S): 7,000 @ $27.64 | EDGAR |
| 2021-03-02 | 4 | Summit Materials, Inc. (SUM) | Option exercise (M): 5,342 · Option exercise (M): 5,342 (derivative) @ $0 | EDGAR |
| 2020-11-13 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 200 @ $452.34 | EDGAR |
| 2020-08-06 | 4 | O REILLY AUTOMOTIVE INC (ORLY) | Sale (S): 250 @ $470.47 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1275195 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs